Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of June 2025. The report specifically details a transaction in own shares executed under the Company's share buyback programme announced on March 28, 2025.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on share repurchase activity.
| Metric | Value |
|---|---|
| Date of Purchase | June 23, 2025 |
| Number of Shares Purchased | 1,008,610 |
| Highest Price Paid (p) | 387.90 |
| Lowest Price Paid (p) | 381.50 |
| Volume Weighted Average Price (p) | 385.10 |
| Registered Share Capital Post-Transaction | 8,990,548,799 ordinary shares |
| Treasury Shares Held | 4,080,205 |
| Voting Shares Outstanding | 8,986,468,594 |
Material Changes
The primary material change reported is the reduction of the Company's share count through the cancellation of 1,008,610 ordinary shares. Consequently, the number of ordinary shares with voting rights is now 8,986,468,594.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, management commentary on operations, or discussion of risks and contingencies. It is a regulatory disclosure of a specific share transaction in compliance with the Market Abuse Regulation.
Key Facts for Investor Verification
- Verify the total number of shares purchased to date under the March 28, 2025 Buyback Programme.
- Confirm the current market price relative to the volume-weighted average purchase price of 385.10 pence.
- Review the full breakdown of individual trades available via the provided London Stock Exchange link for granular execution details.
- Monitor future filings to determine if the Company will continue repurchasing shares under the existing programme or announce a new one.